JP Morgan Chase’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.69M Sell
789,951
-135,222
-15% -$1.03M ﹤0.01% 3208
2025
Q4
$8.99M Buy
925,173
+887,157
+2,334% +$7.54M ﹤0.01% 2780
2025
Q3
$159K Buy
38,016
+1,712
+5% +$10.9K ﹤0.01% 5639
2025
Q2
$337K Sell
36,304
-184,283
-84% -$1.61M ﹤0.01% 4979
2025
Q1
$2.15M Sell
220,587
-266,022
-55% -$3.29M ﹤0.01% 3814
2024
Q4
$5.89M Buy
486,609
+237,260
+95% +$2.88M ﹤0.01% 3198
2024
Q3
$2.73M Buy
249,349
+8,074
+3% +$82K ﹤0.01% 3732
2024
Q2
$2.17M Sell
241,275
-30,858
-11% -$215K ﹤0.01% 3721
2024
Q1
$2.22M Sell
272,133
-32,890
-11% -$270K ﹤0.01% 3745
2023
Q4
$2.57M Sell
305,023
-77,512
-20% -$899K ﹤0.01% 3641
2023
Q3
$6.55M Buy
382,535
+79,616
+26% +$1.56M ﹤0.01% 2633
2023
Q2
$7.03M Buy
302,919
+139,709
+86% +$2.73M ﹤0.01% 2599
2023
Q1
$2.88M Buy
163,210
+10,518
+7% +$250K ﹤0.01% 3269
2022
Q4
$4.15M Sell
152,692
-12,179
-7% -$253K ﹤0.01% 2982
2022
Q3
$2.85M Buy
164,871
+135,173
+455% +$2.58M ﹤0.01% 3184
2022
Q2
$519K Buy
29,698
+9,740
+49% +$160K ﹤0.01% 4524
2022
Q1
$339K Sell
19,958
-361,718
-95% -$6.83M ﹤0.01% 4924
2021
Q4
$10.3M Sell
381,676
-26,255
-6% -$785K ﹤0.01% 2429
2021
Q3
$12.1M Buy
407,931
+58,079
+17% +$1.89M ﹤0.01% 2213
2021
Q2
$13.4M Buy
349,852
+27,547
+9% +$942K ﹤0.01% 2172
2021
Q1
$9.83M Buy
322,305
+122,700
+61% +$4.59M ﹤0.01% 2374
2020
Q4
$7.62M Buy
199,605
+164,047
+461% +$6.84M ﹤0.01% 2435
2020
Q3
$829K Buy
35,558
+29,734
+511% +$678K ﹤0.01% 3745
2020
Q2
$145K Buy
5,824
+1,646
+39% +$29.1K ﹤0.01% 4413
2020
Q1
$41K Sell
4,178
-53,787
-93% -$802K ﹤0.01% 4781
2019
Q4
$832K Buy
57,965
+54,162
+1,424% +$780K ﹤0.01% 3972
2019
Q3
$53K Buy
3,803
+617
+19% +$7.57K ﹤0.01% 5154
2019
Q2
$44K Buy
3,186
+336
+12% +$4.86K ﹤0.01% 5220
2019
Q1
$43K Buy
2,850
+940
+49% +$11.7K ﹤0.01% 5191
2018
Q4
$19K Buy
1,910
+178
+10% +$2.41K ﹤0.01% 5337
2018
Q3
$28K Buy
+1,732
New +$30.4K ﹤0.01% 5358

Other funds holding REPL

JP Morgan Chase's REPL Position: Q1 2026 in Review

JP Morgan Chase reduced its Replimune Group (REPL) stake by 15% in Q1 2026, selling an estimated $1.03M and leaving 789,951 shares worth $5.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3208.

JP Morgan Chase first reported a position in REPL in Q3 2018 and has held it in 31 quarters since. The position peaked at $13.4M in Q2 2021. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • JP Morgan Chase held 789,951 shares of Replimune Group worth $5.69M as of Q1 2026.
  • JP Morgan Chase sold 135,222 Replimune Group shares in Q1 2026, an estimated $1.03M.
  • Replimune Group made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3208 holding.
  • JP Morgan Chase first reported a position in Replimune Group in Q3 2018 and has held it in 31 quarters since.
  • JP Morgan Chase's Replimune Group position peaked at $13.4M in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.